[Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].

Suppr

超能文献

作者信息

Siegfried J, Klaiber R, Perret E, Ziegler W H

出版信息

Dtsch Med Wochenschr. 1969 Dec 26;94(52):2678-81. doi: 10.1055/s-0028-1110503.

DOI:10.1055/s-0028-1110503

PMID:4903342

Abstract

摘要

相似文献

[Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].

Dtsch Med Wochenschr. 1969 Dec 26;94(52):2678-81. doi: 10.1055/s-0028-1110503.

[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].

Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.

Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.

Med J Aust. 1974 Mar 23;1(12):429-32.

[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].

Wien Med Wochenschr. 1974 Jun 1;124(22):340-4.

[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].

Neurol Neurocir Psiquiatr. 1969;10(1):1-25.

[Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].

Nouv Presse Med. 1973 Feb 3;2(5):315-6.

[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].

Presse Med (1893). 1969 Apr 5;77(17):619-22.

[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].

Wien Med Wochenschr. 1973 Jun 30;123(26):433-5.

[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].

Rev Med Chil. 1973 Jun;101(6):452-5.

[Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].

Arch Invest Med (Mex). 1974;5(2):105-16.

引用本文的文献

The pharmacology of Parkinson's disease: basic aspects and recent advances.

Experientia. 1984 Nov 15;40(11):1165-72. doi: 10.1007/BF01946641.

Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.

Can Med Assoc J. 1972 Jun 10;106(11):1169-74.

[Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Arch Psychiatr Nervenkr (1970). 1974 Apr 9;218(4):319-38. doi: 10.1007/BF00342576.

Parkinson's disease and striatal dopamine: in vivo morphological evidence for the presence of dopamine in the human brain.

J Neural Transm. 1974;35(1):13-22. doi: 10.1007/BF01245332.

[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835.

[The therapeutic effect of L-dopa].

Naturwissenschaften. 1972 Nov;59(11):492-6. doi: 10.1007/BF00609813.

[Modern treatment of parkinsonism].

Z Neurol. 1972;202(4):257-80.

Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Z Neurol. 1972;202(1):1-20. doi: 10.1007/BF00316422.

Changes in taste under L-DOPA therapy.

Z Neurol. 1971;200(4):345-8. doi: 10.1007/BF00316598.

Unsuccessful treatment with levodopa of a parkinsonian patient with calcification of the basal ganglia.

J Neurol. 1978 Apr 14;218(1):51-4. doi: 10.1007/BF00314718.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验